MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,000 | -61.3% | 150,000 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $494,000 | -19.9% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $617,000 | -29.8% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $879,000 | -15.8% | 150,000 | -2.5% | 0.00% | 0.0% |
| Q3 2022 | $1,044,000 | +46.4% | 153,793 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $713,000 | +15.6% | 154,418 | 0.0% | 0.00% | – |
| Q1 2022 | $617,000 | -35.7% | 154,418 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $960,000 | -35.1% | 154,418 | -1.5% | 0.00% | 0.0% |
| Q3 2021 | $1,479,000 | -28.1% | 156,764 | +3.5% | 0.00% | -50.0% |
| Q2 2021 | $2,057,000 | -16.1% | 151,498 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $2,451,000 | -39.4% | 151,498 | -0.3% | 0.00% | -50.0% |
| Q4 2020 | $4,044,000 | +42.9% | 151,957 | 0.0% | 0.01% | +20.0% |
| Q3 2020 | $2,829,000 | -20.4% | 151,957 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $3,556,000 | – | 151,957 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |